01-Dec-15 When in May-15 Prime Minister Dmitry Medvedev tasked the government with creating a program of pharmaceutical import substitution, foreign companies were worried. Today, 60% of the drugs approved by the Russian government are produced domestically. Under the new policy, this share should increase to 90% by 2018. [image: Getty Images]

16-Nov-15 In May 2015, the People's Friendship University of Russia (PFUR or RUDN), which has students from 152 countries, established a school of medical information and telemedicine. There are few doctors in Russia who know how to run telemedicine centers, and RUDN is aiming to equip its students with this knowledge. [image: Russian Beyond The Headlines / Press Photo]

28-Oct-15 Healthcare funding provided by Russia's Sverdlovsk Region as part of the obligatory medical insurance package might be reduced 14% to RUB3.8 bn in 2016. The healthcare sector is reported to be on the brink of collapsing, and some clinics might simply go bankrupt. [image: Quartz]

22-Oct-15 Although growth in emerging markets is slowing, Abbott CEO Miles White remains upbeat about the prospects in countries like China. During 3Q 2015, Abbott saw revenue in emerging markets soar 21%. “Policies focused on expanding access to care and favorable trends, including increasing birth rates, aging populations, and adoption of Western standards and technologies, are all driving growth,” said White. [image: MD + DI].

20-Oct-15 AstraZeneca announced a new state-of-the-art manufacturing and packaging facility in Kaluga, Russia, dedicated to the local supply of innovative medicines. In 2011 AstraZeneca was one of the first multinational pharmaceutical companies to announce plans to invest in the construction of a dedicated manufacturing facility in Russia. Four years on, the Company has invested USD224m. [image: AstraZeneca]